Fact CheckerSign in

NCT06582121Recruiting

Study of Sleep Disorders in Prodromal and Definite Parkinsons Disease

Controlled, Multicenter Study of Sleep Disorders in Prodromal and Definite Parkinsons Disease

Source: ClinicalTrials.gov · Last updated 6 Mar 2026

Brief summary (registry, in English)

Multicenter controlled study of sleep disorders in isolated REM Behavior Disorder and Parkinson\'s disease (SOMPARK)

Status (registry)
Recruiting
Study type
Interventional
Enrollment
457 (estimated)
First submitted
30 Aug 2024
Start date
18 Mar 2025
Primary completion date
Apr 2028
Lead sponsor
Assistance Publique - Hôpitaux de Paris
NCT number
NCT06582121

What you commit to

  • Study type: Interventional
  • Planned participants: 457
  • From 18 Mar 2025 to the primary completion date, Apr 2028
  • 6 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Common to all groups:
  • Pregnant or breastfeeding women
  • Subjects under guardianship/conservatorship
  • Persons deprived of liberty.

Who the study is looking for

  • Common to all groups:
  • Age superior 18 years
  • Patients who have received complete information about the study from an investigator and who fully consent to participate.
    • For Parkinson Disease (PD):
  • Patients followed for PD diagnosed according to international criteria for the diagnosis of PD (MDS criteria),
  • A MoCA score greater than 20/30
  • No treatment with deep brain stimulation.
    • For REM Sleep Behavior Disorder (RBD):
  • Diagnosis of RBD according to ICSD-3 criteria: presence on polysomnography of an abnormal elevation of muscle tone during REM sleep (more than 18% of REM sleep without chin atonia) and/or the presence of REM sleep behaviors on video-polysomnography,
  • Absence of progressive neurodegenerative pathology: absence of diagnostic criteria for PD, multiple system atrophy, or Lewy body dementia.
    • For healthy controls:
    • \- No neurological or psychiatric disease

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (6)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
CHU de Clermont-Ferrand
Coordinator of this site? Confirm its status
Clermont-FerrandFranceRecruiting
CHU de Lille
Coordinator of this site? Confirm its status
LilleFranceRecruiting
CHU de Lyon
Coordinator of this site? Confirm its status
LyonFranceRecruiting
CHU de Nantes
Coordinator of this site? Confirm its status
NantesFranceRecruiting
CHU de Nîmes
Coordinator of this site? Confirm its status
NîmesFranceRecruiting
CHU Pitie Salpetriere
Coordinator of this site? Confirm its status
ParisFranceRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.